Page last updated: 2024-08-24

simendan and Transposition of Great Vessels

simendan has been researched along with Transposition of Great Vessels in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boethig, D; Goerler, H; Huber, D; Osthaus, WA; Sasse, M; Sümpelmann, R; Winterhalter, M1
Lechner, E; Mair, R; Moosbauer, W; Pinter, M; Tulzer, G1

Other Studies

2 other study(ies) available for simendan and Transposition of Great Vessels

ArticleYear
First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
    European journal of pediatrics, 2009, Volume: 168, Issue:6

    Topics: Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Intraoperative Period; Lactic Acid; Length of Stay; Oxygen; Postoperative Complications; Pyridazines; Respiration, Artificial; Retrospective Studies; Simendan; Transposition of Great Vessels

2009
Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2007, Volume: 8, Issue:1

    Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Follow-Up Studies; Gestational Age; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Pediatric; Male; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan; Time Factors; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2007